BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6161729)

  • 1. Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease.
    Nowak FG; Cocco G; Chu D; Gasser DF
    Clin Cardiol; 1980 Dec; 3(6):371-6. PubMed ID: 6161729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) (author's transl)].
    Menzel T; Kirchner P; Cocco G; Gasser DF
    Z Kardiol; 1981 Mar; 70(3):163-71. PubMed ID: 6165153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cardiac arrhythmias with tiapamil.
    Brisse B; Bender F; Bramann H; Kuhs H; Schwippe G
    Cardiology; 1982; 69 Suppl():144-8. PubMed ID: 7151076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tiapamil on perioperative cardiac arrhythmias and myocardial function.
    List WF; Metzler H
    Cardiology; 1982; 69 Suppl():157-64. PubMed ID: 6185222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimeditiapramine (Ro 11-1781), a new calcium antagonist, in the management of supraventricular tachyarrhythmias in patients with acute myocardial infarction.
    Cocco G; Chu D; Strozzi C
    Clin Cardiol; 1979 Apr; 2(2):131-4. PubMed ID: 262567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiapamil in the management of supraventricular arrhythmias occurring after acute myocardial infarction.
    Strozzi C; Sfrisi C; Leutenegger F; Padula A; Bulgarelli R
    Cardiology; 1982; 69 Suppl():187-91. PubMed ID: 7151079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effect of tiapamil in patients with acute myocardial infarction.
    Dubner S; Gimeno G; Elencwajg B; Quinteiro R; Tronge J; Bertolasi C
    Cardiology; 1982; 69 Suppl():172-80. PubMed ID: 7151078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
    Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
    Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs.
    Shargorodsky BM; Braun S; Belhassen B; Laniado S
    Cardiovasc Res; 1986 Sep; 20(9):652-7. PubMed ID: 3791354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
    Lessem J
    Cardiology; 1982; 69 Suppl():199-208. PubMed ID: 7151080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
    Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
    Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium ion antagonists in supraventricular and ventricular arrhythmias.
    Schamroth L
    Cardiology; 1982; 69 Suppl():140-3. PubMed ID: 7151075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K; Bischoff KO; Menken U; Hager W
    Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
    Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
    Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of tiapamil and propranolol assessed from the reduction of ventricular arrhythmias in the cycloergometer test. A double-blind study.
    Cocco G; De Gori D; Burkart F; Leishman B
    Cardiology; 1982; 69 Suppl():181-6. PubMed ID: 6185223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral effectiveness of the calcium-antagonist Ro 11-1781 (Tiapamil) in supraventricular and ventricular extrasystoles (author's transl)].
    Steffen E; Langbehn AF; Diederich KW
    Z Kardiol; 1981 Mar; 70(3):172-5. PubMed ID: 6165154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial M-mode echocardiography in evaluation of the cardiovascular effects of tiapamil and their relationship to plasma levels in patients with coronary heart disease.
    Lindvall K; Cocco G; Wendt G; Chu D; Heizmann P
    Int J Cardiol; 1981; 1(1):15-24. PubMed ID: 7333712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: randomized double-blind trial.
    Danchin N; Clozel JP; Khalife K; Elkik F; Boulay F; Neimann JL; Cherrier F
    Am Heart J; 1985 Apr; 109(4):764-8. PubMed ID: 3885699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.